Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
cancer
News
Lilly Plans Two New Drugs a Year Starting in 2013, China Focus
Bloomberg
Alzheimer's disease
cancer
China
diabetes
Eli Lilly
pipelines
»
9 comments
News
Isis reacquires rights to drug, will revamp cancer program
San Diego Union Tribune, CA
cancer
Eli Lilly
Isis Pharmaceuticals
»
2 comments
News
Novartis seeks to broaden use of some cancer drugs
Marketwatch
cancer
Novartis
Tasigna
Zometa
»
3 comments
News
Novartis' Cancer Plan
Forbes
Afinitor
cancer
Gleevac
Novartis
Tasigna
»
122 comments
News
Onyx Treatment Fights Cancer With Few Side Effects
Bloomberg
cancer
Multiple Myeloma
ONYX Pharmaceuticals
»
5 comments
News
Immunogen lifted by cancer-drug trial
Bizjournals.com
cancer
drug trials
Immunogen
»
160 comments
News
Introducing the $30,000 Per Month Cancer Drug
WSJ Online
Allos
cancer
Folotyn
lymphoma
»
Login
or
register
to post comments
News
Cephalon’s Treanda Poised for 10-Fold Sales Surge
Bloomberg
cancer
Cephalon
Treanda
»
Login
or
register
to post comments
News
Keryx Biopharmaceuticals cancer drug candidate gets faster regulatory review by FDA
Yahoo/AP
cancer
FDA
Keryx
perifosine
»
Login
or
register
to post comments
News
Celgene Cancer Pill to Triple Sales on Threat to J&J
Bloomberg
cancer
Celgene
JNJ
Revlimid
Velcade
»
1 comment
« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT